A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal
Table 2
SGZ performance as a function of tumor purity in the cell line dataset.
SGZ performance as a function of tumor purity in the cell line dataset.